VERSACLOZ

This brand name is authorized in United States. It is also authorized in Australia, New Zealand.

Active ingredients

The drug VERSACLOZ contains one active pharmaceutical ingredient (API):

1	Clozapine UNII J60AR2IKIC - CLOZAPINE
	Clozapine has been shown to be an antipsychotic agent that is different from classic antipsychotics. Clozapine has potent anti-alpha-adrenergic, anticholinergic, antihistaminic, and arousal-reaction-inhibiting effects. It has also been shown to possess antiserotoninergic properties.
	Read more about Clozapine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
VERSACLOZ Oral suspension	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N05AH02	Clozapine	N Nervous system → N05 Psycholeptics → N05A Antipsychotics → N05AH Diazepines, oxazepines and thiazepines
Discover more medicines within N05AH02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	11415T, 11422E, 11433R
NZ	Medicines and Medical Devices Safety Authority	21067
US	FDA, National Drug Code	52817-601